PYY 1562 / Novo Nordisk - LARVOL DELTA

A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese (clinicaltrials.gov) - P1; N=37; Completed; Sponsor: Novo Nordisk A/S; Active, not recruiting ➔ Completed

Clinical • Trial completion

A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese (clinicaltrials.gov) - P1; N=37; Active, not recruiting; Sponsor: Novo Nordisk A/S; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed